27262. Adulteration and misbranding of Ovestrumon.    U. S. v. 1 Box, et al., of 
Ovestrumon.    Default decree of condemnation and destruction.    (F. & D.
no. 36811.    Sample no. 40718-B.)
This product fell below the professed standard under which it was sold; and 
the labeling contained false and fraudulent curative and therapeutic claims.
On December 21, 1935, the United States attorney for the Western District 
of Washington, acting upon a report by the Secretary of Agriculture, filed in 
the district court a libel praying seizure and condemnation of 13 boxes of 
2-cubic centimeter ampuls of Ovestrumon at Seattle, Wash., alleging that it had 
been shipped in interstate commerce on or about April 11, April 15, and October 
11, 1935, by United Laboratories, Inc.,. from Pasadena, Calif., and charging 
adulteration and misbranding in violation of the Food and Drugs Act as 
amended.
Analysis of a sample of the article showed that it was inert.
It was alleged to be adulterated in that its strength fell below the professed 
standard or quality under which it was sold, namely, "Ovestrumon A stand- 
ardized Extract Containing the Estrus Producing Hormone of The Ovary."
It was alleged to be misbranded in that the following statements appearing 
upon and within the package, (carton) "Ovestrumon A Standardized Estrus 
(Containing the Estrus Producing Hormone of The Ovary", and (circular) 
"Preparation Ovestrumon is carefully prepared from fresh tissues to contain 
the correct balance between the corpus luteum and the follicles. The method 
of production peculiar to this laboratory, enables all the hormones present to 
be utilized, as is not the case in products prepared from the dried glands. 
Ovestrumon is a stable product and will not deteriorate with age", were false 
and misleading. The article was alleged to be misbranded further in that the 
statements appearing in the circular within the package, "Indications For Use:
Ovestrumon Is useful In any and all of the symptoms which accompany the 
menopause. It is exceedingly valuable in the treatment of the nausea and 
vomiting of pregnancy. It has a distinct place in the treatment of the neuroses 
common with young women which are now known to be, in many cases, due to 
Insufficient and altered ovarian hormones. Dosage. The dosage necessary will 
be apparent from the symptoms of the case, from one to three injections a 
week of 2 cc being usual", regarding its curative or therapeutic effects were 
false and fraudulent, since it contained no ingredients or combination of in- 
gredients capable when used as directed, of producing the effects claimed.
The United Laboratories, Ltd., having appeared and subsequently having 
withdrawn its appearance, a default decree of condemnation was entered on 
May 30, 1937, and the product was ordered destroyed.
H. A. WAIXACB, Secretary of Agriculture.